TrialAnnals of the rheumatic diseases2007

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.

M E Farkouh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.